Skip to Content

Dihydrotachysterol Pregnancy and Breastfeeding Warnings

Dihydrotachysterol is also known as: DHT, DHT Intensol, Hytakerol

Dihydrotachysterol Pregnancy Warnings

Supplementation of vitamin D during the third trimester with vitamin D2 or vitamin D3 has been studied. Dosages of 1000 Intl units per day given daily during the third trimester did not result in any adverse fetal outcome. Neonatal calcium homeostasis was affected, resulting in significantly higher concentrations of calcium, 25-OH vitamin D3, and 1,25-(OH)2 vitamin D3. Earlier literature expressed concerns over the development of supravalvular aortic stenosis, craniofacial abnormalities, and dental abnormalities in infants and children with idiopathic hypercalcemia. Whether or not prenatal factors predisposed these children to the development of hypercalcemia is not known. Fifteen hypoparathyroid women receiving 50,000 to 250,000 Intl units of vitamin D2 experienced 27 uneventful births. No cardiovascular or craniofacial abnormalities were reported.

Dihydrotachysterol (vitamin D3) has been assigned to pregnancy category C. There are no controlled data in human pregnancy. Dihydrotachysterol should only be used during pregnancy when benefit outweighs the risk.

See references

Dihydrotachysterol Breastfeeding Warnings

There are no data on the excretion of dihydrotachysterol into human milk.

See references

References for pregnancy information

  1. Mallet E, Gugi B, Brunelle P, Henocq A, Basuyau JP, Lemeur H "Vitamin D supplementation in pregnancy: a controlled trial of two methods." Obstet Gynecol 68 (1986): 300-4
  2. Taussig HB "Possible injury to the cardiovascular system from vitamin D." Ann Intern Med 65 (1966): 1195-200
  3. "Product Information. DHT (dihydrotachysterol)." Roxane Laboratories Inc, Columbus, OH.
  4. Delvin EE, Salle BL, Glorieux FH, Adeleine P, David LS "Vitamin D supplementation during pregnancy: effect on neonatal calcium homeostasis." J Pediatr 109 (1986): 328-34
  5. Lester GE "Cholecalciferol and placental calcium transport." Fed Proc 45 (1986): 2524-7
  6. Goodenday LS, Gordon GS "No risk from vitamin D in pregnancy." Ann Intern Med 75 (1971): 807-8
  7. Rowe RD, Cooke RE "Vitamin D and craniofacial and dental anomalies of supravalvular stenosis." Pediatrics 43 (1969): 1-2

References for breastfeeding information

  1. "Product Information. DHT (dihydrotachysterol)." Roxane Laboratories Inc, Columbus, OH.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide